tramiprosate has been researched along with Diabetes Mellitus, Type 1 in 1 studies
tramiprosate: GABA receptor agonist and a glycosaminoglycan mimetic; has nootropic acitivity; structure; a sulfonate analog of GABA
3-aminopropanesulfonic acid : An amino sulfonic acid that is the 3-amino derivative of propanesulfonic acid.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, J | 1 |
| Dang, H | 1 |
| O'Laco, KA | 1 |
| Song, M | 1 |
| Tiu, BC | 1 |
| Gilles, S | 1 |
| Zakarian, C | 1 |
| Kaufman, DL | 1 |
1 other study available for tramiprosate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Homotaurine Treatment Enhances CD4
Topics: Animals; Blood Glucose; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Diabetes Mellitus, E | 2019 |